An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients.
about
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsAnti-idiotypic antibodies as cancer vaccines: achievements and future improvementsRacotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataPhysicochemical and biological characterization of 1E10 anti-idiotype vaccine.NGcGM3 ganglioside: a privileged target for cancer vaccinesRacotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Gangliosides as therapeutic targets for cancer.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive SystemDetection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.Cancer vaccines and carbohydrate epitopes.Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast CancerP3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties.Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective.Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsAnti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3.Disialoganglioside directed immunotherapy of neuroblastoma.Anti-idiotype antibodies in cancer treatment.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.Antibody recognition of carbohydrate epitopes†.Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions.Glycans as targets for therapeutic antitumor antibodies.Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Anti-idiotypic antibody mimicking a T-antigen-specific lectin inhibits human epithelial tumor cell proliferation.Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice.Racotumomab for treating lung cancer and pediatric refractory malignancies.The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Corrigendum: involvement of a non-human sialic Acid in human cancer.Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma.Connecting immunology research to public health: Cuban biotechnology.
P2860
Q26769884-8E20125E-534A-43E5-868F-543925613413Q26771367-6A07179A-3622-4ABA-B6FD-C2D7A48166A2Q28278814-14C673B8-F284-4956-997F-B47F281E5241Q30575331-14266E7A-09EA-4172-A299-CE5CA6D5709AQ34080417-9B38AD16-12F1-4995-98A4-EA2BDE36CA11Q34247856-5C9A317A-3327-488F-9C4A-318FE32ACD51Q34449304-A0F943B0-96F3-4D18-B0C2-38299939DE8DQ35128665-699E6008-00C5-4C5A-B6C9-5A20B6DE0035Q35200716-18D4F8EC-4246-45AE-B615-F7EB3145C1D8Q35224101-157E55C1-0006-4DF5-8A6A-B1161F58800FQ35525289-BF2A51FD-9BCF-4EB3-AA64-5EDD42BD6F3CQ35684309-E3C55749-4AA5-4CD8-A4A4-54AEE2E443C5Q35684466-ACA6CCDC-3B51-4CC5-AA45-0BAEF44D6782Q35928091-D134ECDC-08F1-4A9E-9031-93542443F951Q36352693-DDEE2B88-F15C-407E-869A-CE817579528CQ36382557-938CA780-0D0C-424F-AAD4-735C39B8D790Q36386109-54E12F30-825F-4C6D-8C28-E774C885CDA5Q36410563-83F7B65F-B6CE-4409-A4D3-02C578075EEAQ36540352-4E811781-7EFA-46CA-B41E-67A852009226Q36761416-3BBFA1DA-8493-4E45-8DF3-2F03DC475A1EQ36832098-9CB6FAEB-6763-4F57-B76D-75DF61DF8BA8Q37594945-BB08458D-FDC0-4CDD-BD9E-B7AAB0A87822Q37773248-D363B734-0630-4031-A4E9-1ABC651B33ABQ37840398-03472801-DEC6-4E0C-80BA-54735D5B9A92Q37962075-2A46F290-EE49-437F-8214-78A90DF39606Q38034815-C981B88E-260F-4F13-84F0-CE27F83613E9Q38207923-FE3AC4D0-15E7-4065-BF73-649B7751B01BQ38344729-6BD9F29A-7BA8-491B-95D0-62900370773CQ38727803-B8B43A52-EB7D-43B1-AD03-328104E38AF0Q38745411-9D25B4DF-41FC-410C-892F-FDB1AA1183FFQ38786934-79D7F33B-05D5-4FC4-AB00-6E294F856A19Q38848896-A1308173-79F9-43D6-9A4D-E5EB20D91D9FQ38988791-1482BA78-A412-4404-B8D4-D8D14C8559C3Q39210534-15E5D80D-C024-4E29-938E-329929C44CC7Q39907334-2B1258E6-9478-4743-8AD7-D2EDAA9C9A9EQ46801745-52D6F788-696F-4E91-8C9A-B24C92154E69
P2860
An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@en
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@nl
type
label
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@en
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@nl
prefLabel
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@en
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@nl
P2093
P1476
An anti-idiotype vaccine elici ...... njugates in melanoma patients.
@en
P2093
Alain Díaz
Alexis Pérez
Ana María Hernández
Ana María Vázquez
Edmundo Rodríguez
Mauro Alfonso
Roberto Bitton
Rolando Pérez
P304
P356
10.4049/JIMMUNOL.168.5.2523
P407
P577
2002-03-01T00:00:00Z